Relief Therapeutics Holding (Relief Therapeutics Holding) Additional Paid-In Capital : $0.00 Mil(As of Jun. 2023)

View and export this data going back to 1990. Start your Free Trial

What is Relief Therapeutics Holding Additional Paid-In Capital?

Relief Therapeutics Holding's quarterly additional paid-in capital increased from Jun. 2022 ($0.00 Mil) to Dec. 2022 ($231.52 Mil) but then stayed the same from Dec. 2022 ($231.52 Mil) to Jun. 2023 ($0.00 Mil).

Relief Therapeutics Holding's annual additional paid-in capital increased from Dec. 2020 ($77.16 Mil) to Dec. 2021 ($225.32 Mil) and increased from Dec. 2021 ($225.32 Mil) to Dec. 2022 ($231.52 Mil).

Relief Therapeutics Holding Additional Paid-In Capital Historical Data

The historical data trend for Relief Therapeutics Holding's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Additional Paid-In Capital Chart

Relief Therapeutics Holding Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

20.87

20.81

77.16

225.32

231.52

Relief Therapeutics Holding Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial															-	225.32	-	231.52	-

Relief Therapeutics Holding Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Relief Therapeutics Holding Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding (Relief Therapeutics Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

RLFTY:USA RLFz:UK RLF:Switzerland

Address

Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.